CDMO market size | Forecast and Future Outlook 2025

Q: Which segments are driving CDMO market growth?

Biologics and small molecule APIs are the leading segments due to increasing demand for high-quality, outsourced pharmaceutical services.

Q: What challenges does the CDMO market face?

Capacity constraints, technology transfer complexities, and maintaining regulatory compliance across geographies remain core challenges.

Q: What is supporting rapid CDMO adoption?

The rise of virtual biotech companies and need for flexible, scalable solutions are prompting more pharma firms to engage CDMO partnerships.

Q: How are innovations shaping the CDMO industry?

Digital twins, single-use technologies, and continuous manufacturing systems are modernizing the CDMO landscape for better efficiency and compliance.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA4141

Publication Date: Jun 2025

What is the CDMO Market Size?

According to 6Wresearch internal database and industry insights, the Global Contract Development and Manufacturing Organization (CDMO) market was estimated at approximately USD 145 billion in 2024 and is expected to surpass USD 289 billion by 2031, exhibiting a CAGR of 10.1%.

This growth is driven by rising outsourcing in the pharmaceutical sector, increased demand for biologics, and the need for cost-effective drug development and manufacturing.

Key Growth Drivers

Surge in demand for large and small molecule drug development.
Expansion of biologics and advanced therapy medicinal products (ATMPs).
Cost efficiency and scalability offered by CDMO partnerships.
Growing number of virtual and small biotech firms lacking in-house capabilities.
Accelerated timelines for clinical trials and drug commercialization.
Increasing regulatory compliance requirements prompting external support.

CDMO Market Trends

CDMO Market is expected to evolve with trends such as greater integration of digital manufacturing platforms, AI-powered process optimization, and expansion in biologics-focused facilities. The increased need of fill-finish solutions, personalized healthcare, and modular manufacturing units is transforming the way the operations happen. Moreover, the CDMOs are stepping up in terms of the global GMP-compliant infrastructure to respond to the increased expectations of global regulatory authorities as well as pharmaceutical innovators. CDMOs and biotech firm strategic partnerships are also up and contribute to pipeline support. Further, there is a rise in promoting sustainability and energy-saving production throughout CDMO activity.